✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Thymic Peptide Research Compound
Thymosin Alpha-1 is a peptide studied in laboratory settings for its role in immune system signaling and regulation pathways. Research commonly examines its influence on T-cell activity, cytokine modulation, and broader immune response mechanisms in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Thymosin Alpha-1 is a synthetic peptide analogue of a naturally occurring thymic hormone involved in immune signaling research. It is developed for controlled laboratory investigation within experimental environments.
In scientific literature, Thymosin Alpha-1 is studied in models examining immune cell signaling pathways, cytokine modulation frameworks, and receptor-mediated regulatory systems under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
Thymosin Alpha-1 is a 28–amino acid peptide derived from prothymosin alpha and has been evaluated in research focused on immune-related signaling systems. Experimental studies examine its interaction with immune cell regulatory pathways and cytokine-associated signaling mechanisms within controlled laboratory environments.
Research publications have explored its receptor interaction dynamics and pathway-level regulatory frameworks under structured study conditions.
Thymosin Alpha-1 was identified during early investigations into thymic hormones and immune system regulation. Subsequent biochemical research isolated active peptide fragments responsible for signaling activity within immune-related pathways.
Over time, synthetic analogues were developed to allow controlled experimental study of thymic peptide signaling systems and immune regulatory frameworks.
Laboratory investigations into Thymosin Alpha-1 have focused on immune cell signaling models, cytokine-associated pathway studies, and receptor-mediated regulatory systems. Research frameworks evaluate peptide interaction within immune signaling environments under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized Thymosin Alpha-1. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Thymosin alpha-1 stimulates endothelial cell migration, angiogenesis, and wound healing.
PubMedImpact of the immunomodulating peptide thymosin alpha-1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
PubMedThymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells. Clin Infect Dis 71(16):2150–2157.
PubMedA Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection. J Infect Dis 227(11):1255–1265.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
Synthetic thymosin beta analog studied for cellular migration, actin regulation, and repair signaling pathways
From$60.00
